Special Stains vs. Immunohistochemistry: What They Are and When Your Pathologist Uses Each
When your pathology report recommends additional testing, it's either chemistry or antibodies — and the choice between them tells you a lot about what question the case is raising.
Acanthomatous Ameloblastoma: When the Margins Tell the Real Story
Canine acanthomatous ameloblastoma doesn't metastasize. The entire prognosis lives in the surgical margin — and this case shows exactly why that number needs context to mean anything.
Nodular Dermatofibrosis and Renal Cystadenocarcinoma: Recognizing a Skin Lesion That Points Inward
Multiple firm nodules on a German Shepherd's legs have a differential list. Nodular dermatofibrosis should be on it — because the diagnosis it points to is bilateral renal cystadenocarcinoma
Liquid Biopsy and Circulating Tumor DNA: Where Veterinary Oncology Diagnostics Are Headed
Liquid biopsy is here. The question is no longer whether it has a role in veterinary oncology — it's understanding what that role is today and where it's going in the next few years.
NGS in Veterinary Oncology: What's Commercially Available Now and Where It's Headed
…next-generation sequencing (NGS) has arrived in veterinary medicine, but it remains in early clinical adoption, the available assays are almost exclusively validated for dogs, and these tools work best as an adjunct to histopathology rather than a replacement for it. This post offers an honest overview of where things stand today — what you can actually order, what the evidence shows, and where the field is likely headed.